BioCentury | Jun 6, 2011
Company News

Merck KGaA sales and marketing update

...Merck's EMD Serono Inc. division launched Cyanokit hydroxocobalamin in Canada to treat cyanide poisoning. Cyanokit is...
BioCentury | Apr 12, 2010
Company News

Swedish Oprhan Biovitrum, Merck KGaA sales and marketing update

...the U.K. and the Netherlands to the territories in which Swedish Orphan Biovitrum distributes Merck's Cyanokit...
...precursor of vitamin B12 is approved to treat cyanide poisoning. Swedish Orphan Biovitrum already distributes Cyanokit...
BioCentury | Nov 2, 2009
Company News

King, Merck KGaA sales and marketing update

...Merck's Merck Sante S.A.S. subsidiary granted King exclusive rights to commercialize Cyanokit hydroxocobalamin in the U.S...
...the U.S., where it is approved to treat known or suspected cyanide poisoning. King said Cyanokit...
BioCentury | Mar 24, 2008
Company News

Merck KGaA sales and marketing update

...Merck KGaA's Merck Serono S.A. subsidiary launched Cyanokit hydroxocobalamin to treat known or suspected cyanide poisoning...
BioCentury | Dec 3, 2007
Clinical News

Cyanokit hydoxocobalamin regulatory update

...The EC approved an MAA for Cyanokit hydroxocobalamin to treat known or suspected cyanide poisoning in...
...the U.S. and Japan for the same indication. Merck KGaA (FSE:MRK), Darmstadt, Germany Product: Cyanokit hydoxocobalamin...
BioCentury | Oct 1, 2007
Clinical News

Cyanokit hydoxocobalamin regulatory update

...EMEA's CHMP issued a positive opinion for Cyanokit hydoxocobalamin to treat known or suspected cyanide poisoning...
...approved in the U.S. for the same indication. Merck KGaA (FSE:MRK), Darmstadt, Germany Product: Cyanokit hydoxocobalamin...
BioCentury | Apr 2, 2007
Company News

Merck KGaA sales and marketing update

...MRK's Dey L.P. subsidiary launched its Cyanokit 5 g Antidote hydroxocobalamin to treat cyanide poisoning in...
BioCentury | Jan 1, 2007
Finance

4Q approvals

...infection following elective colorectal surgery in adults Merck KGaA (FSE:MRK) FDA approves an NDA for Cyanokit...
BioCentury | Jan 1, 2007
Clinical News

Cyanokit hydoxocobalamin regulatory update

...Cyanokit hydroxocobalamin to treat known or suspected cyanide poisoning. Merck's Dey LP subsidiary will market Cyanokit...
...expects to launch the product early this year. Merck KGaA (FSE:MRK), Darmstadt, Germany Product: Cyanokit hydoxocobalamin...
BioCentury | Jun 26, 2006
Clinical News

Cyanokit hydoxocobalamin regulatory update

...MRK's subsidiary EMD Pharmaceuticals Inc. (Durham, N.C.) submitted an NDA to the FDA for Cyanokit to...
...Cyanokit is marketed in France for the same indication. Merck KGaA (FSE:MRK), Darmstadt, Germany Product: Cyanokit...
...is marketed in France for the same indication. Merck KGaA (FSE:MRK), Darmstadt, Germany Product: Cyanokit hydoxocobalamin...
Items per page:
1 - 10 of 11